Clinical Trial Update: Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on TT-00420 tablets with toripalimab for advanced urological tumors (Phase 1/2) with conditions including clear cell renal carcinoma and u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Clear Cell Renal Carcinoma
• Urothelial Carcinoma

Drugs mentioned

• TT-00420 (Tinengotinib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Clear Cell Renal Carcinoma, Urothelial Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN